We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$524M
AUM Growth
+$32.8M
Cap. Flow
-$6.68M
Cap. Flow %
-1.28%
Top 10 Hldgs %
32.2%
Holding
157
New
6
Increased
38
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$3.58M
2
ITRI icon
Itron
ITRI
+$1.9M
3
LLY icon
Eli Lilly
LLY
+$1.83M
4
LNN icon
Lindsay Corp
LNN
+$1.79M
5
EME icon
Emcor
EME
+$1.22M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.98M
2
ECF
Ellsworth Growth & Income Fund
ECF
+$2M
3
ADM icon
Archer Daniels Midland
ADM
+$1.97M
4
DAR icon
Darling Ingredients
DAR
+$1.65M
5
PGJ icon
Invesco Golden Dragon China ETF
PGJ
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 24.97%
2 Industrials 17.47%
3 Technology 16.95%
4 Energy 9%
5 Utilities 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRC
26
DELISTED
DRESSER-RAND GROUP INC
DRC
$6.13M 1.17%
102,760
+8,400
+9% +$498K
AZTA icon
27
Azenta
AZTA
$1.3B
$5.96M 1.14%
568,538
+14,750
+3% +$146K
LNN icon
28
Lindsay Corp
LNN
$1.14B
$5.81M 1.11%
70,228
+22,950
+49% +$1.79M
MDU icon
29
MDU Resources
MDU
$4.18B
$5.45M 1.04%
469,040
-16,174
-3% -$182K
NEE icon
30
NextEra Energy
NEE
$184B
$5.41M 1.03%
252,800
-6,800
-3% -$143K
SIAL
31
DELISTED
SIGMA - ALDRICH CORP
SIAL
$4.96M 0.95%
52,725
-2,450
-4% -$213K
CSCO icon
32
Cisco
CSCO
$443B
$4.81M 0.92%
214,433
-990
-0.5% -$21.9K
MDT icon
33
Medtronic
MDT
$112B
$4.63M 0.88%
80,689
-1,400
-2% -$79.4K
POR icon
34
Portland General Electric
POR
$5.82B
$4.53M 0.86%
149,985
-1,400
-0.9% -$41.1K
TMO icon
35
Thermo Fisher Scientific
TMO
$214B
$4.4M 0.84%
39,500
-950
-2% -$94.5K
EWS icon
36
iShares MSCI Singapore ETF
EWS
$1.04B
$4.37M 0.83%
166,013
– –
TMP icon
37
Tompkins Financial
TMP
$1.42B
$4.34M 0.83%
84,450
-1,500
-2% -$73K
FLS icon
38
Flowserve
FLS
$8.94B
$4.29M 0.82%
54,435
-3,100
-5% -$215K
STE icon
39
Steris
STE
$22.9B
$4.16M 0.79%
86,500
-2,670
-3% -$122K
PG icon
40
Procter & Gamble
PG
$340B
$4.07M 0.78%
50,007
-1,050
-2% -$85.5K
GOOG icon
41
Alphabet (Google) Class C
GOOG
$4.11T
$4.03M 0.77%
144,379
-10,680
-7% -$270K
XRAY icon
42
Dentsply Sirona
XRAY
$2.84B
$3.73M 0.71%
77,050
-4,190
-5% -$196K
OVV icon
43
Ovintiv
OVV
$17B
$3.6M 0.69%
39,870
-5,010
-11% -$456K
YAO
44
DELISTED
Invesco China All-Cap ETF
YAO
$3.59M 0.68%
131,519
-500
-0.4% -$13.5K
LLY icon
45
Eli Lilly
LLY
$1.08T
$3.51M 0.67%
68,838
+36,490
+113% +$1.83M
ZOLT
46
DELISTED
ZOLTEK COMPANIES INC
ZOLT
$3.34M 0.64%
199,401
-26,500
-12% -$443K
CHL
47
DELISTED
China Mobile Limited
CHL
$3.32M 0.63%
63,550
+14,465
+29% +$770K
DIS icon
48
Walt Disney
DIS
$171B
$3.24M 0.62%
42,427
-1,000
-2% -$69.3K
AAPL icon
49
Apple
AAPL
$4.97T
$3.19M 0.61%
158,984
-2,688
-2% -$50.8K
ITRI icon
50
Itron
ITRI
$4.54B
$3.17M 0.61%
76,600
+44,700
+140% +$1.9M
1
2
3 4 5

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
SF
Symphony Financial Houston, Texas $755M AUM 25.99% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return

John G. Ullman & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, John G. Ullman & Associates held 157 positions worth $524M, up 6.7% from $491M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates's Q4 2013 filing shows 6 new, 38 increased, 96 reduced and 8 closed positions. Its largest new stake was Emcor: 31,300 shares worth $1.33M. The largest sale was Bristol-Myers Squibb, an estimated $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q4 2013 buy was Emcor: 31,300 shares worth $1.33M.
  • John G. Ullman & Associates added most to IBM in Q4 2013, an estimated $3.58M increase.
  • John G. Ullman & Associates's biggest Q4 2013 reduction was Bristol-Myers Squibb, cutting an estimated $2.98M.
  • John G. Ullman & Associates fully exited Darling Ingredients in Q4 2013, selling an estimated $1.65M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $524M portfolio in Q4 2013.
  • John G. Ullman & Associates opened 6 new positions and closed 8 in Q4 2013.
  • John G. Ullman & Associates's portfolio value rose 6.7% quarter-over-quarter to $524M.

Based on John G. Ullman & Associates's 13F filing for Q4 2013, filed 3 Feb 2014.